FOCUS ISSUE: PLAQUE NEOVASCULARIZATION, HEMORRHAGE, AND VULNERABILITY: STATE-OF-THE-ART PAPER
Plaque Neovascularization and Antiangiogenic Therapy for Atherosclerosis
Brendan Doyle, MD* and
Noel Caplice, MD, PhD ,*
* Division of Cardiovascular Diseases, Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota
Centre for Research in Vascular Biology, Biosciences Institute, University College Cork, Cork, Ireland
Manuscript received May 24, 2006;
revised manuscript received December 12, 2006,
accepted January 18, 2007.
* Reprint requests and correspondence: Dr. Noel Caplice, Centre for Research in Vascular Biology, Biosciences Institute, University College Cork, Co. Cork, Ireland. (Email: n.caplice{at}ucc.ie).
The concept that neovascularization of the vessel wall may play a fundamental role in the pathophysiology of atherosclerosis was proposed more than a century ago. In recent years, supportive experimental evidence for this hypothesis (such as the finding that neointimal microvessels may increase delivery of cellular and soluble lesion components to the vessel wall) has been underscored by clinical studies associating plaque angiogenesis with more rapidly progressive high-grade disease. Attention has also focused on a possible role for microvessel-derived intraplaque hemorrhage in the development of acute lesion instability. The interest of clinicians in this phenomenon has been spurred by the potential to target vessel wall neovascularization with angiogenesis inhibitors, a therapeutic approach that has been associated with impressive reductions in plaque progression in animal models of vascular disease. The rationale for pursuing an "antiangiogenic" strategy in the treatment of patients with vascular disease, and a framework for further preclinical evaluation of such therapy, is presented here.
|
Abbreviations and Acronyms
| | HIF = hypoxia inducible factor | | VEGF = vascular endothelial growth factor |
|
This article has been cited by other articles:
|
|
|
|
 
A. Thapar, J. Shalhoub, M. Averkiou, C. Mannaris, A. H. Davies, and E. L. S. Leen
Dose-Dependent Artifact in the Far Wall of the Carotid Artery at Dynamic Contrast-enhanced US
Radiology,
February 1, 2012;
262(2):
672 - 679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. E. Eriksson
Intravital Microscopy on Atherosclerosis in Apolipoprotein E-Deficient Mice Establishes Microvessels as Major Entry Pathways for Leukocytes to Advanced Lesions
Circulation,
November 8, 2011;
124(19):
2129 - 2138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Kyriakakis, M. Cavallari, D. Pfaff, D. Fabbro, J. Mestan, M. Philippova, G. De Libero, P. Erne, and T. J. Resink
IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation
J. Leukoc. Biol.,
November 1, 2011;
90(5):
929 - 939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Folco, Y. Sheikine, V. Z. Rocha, T. Christen, E. Shvartz, G. K. Sukhova, M. F. Di Carli, and P. Libby
Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages: Implications for Imaging Atherosclerosis With 18Fluorine-Labeled 2-Deoxy-D-Glucose Positron Emission Tomography
J. Am. Coll. Cardiol.,
August 2, 2011;
58(6):
603 - 614.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-B. Michel, R. Virmani, E. Arbustini, and G. Pasterkamp
Intraplaque haemorrhages as the trigger of plaque vulnerability
Eur. Heart J.,
August 2, 2011;
32(16):
1977 - 1985.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Vancraeynest, A. Pasquet, V. Roelants, B. L. Gerber, and J.-L. J. Vanoverschelde
Imaging the Vulnerable Plaque
J. Am. Coll. Cardiol.,
May 17, 2011;
57(20):
1961 - 1979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Akahori, T. Tsujino, Y. Naito, M. Matsumoto, M. Lee-Kawabata, M. Ohyanagi, M. Mitsuno, Y. Miyamoto, T. Daimon, H. Hao, et al.
Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis
Eur. Heart J.,
April 1, 2011;
32(7):
888 - 896.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Staub, S. Partovi, A. F. L. Schinkel, B. Coll, H. Uthoff, M. Aschwanden, K. A. Jaeger, and S. B. Feinstein
Correlation of Carotid Artery Atherosclerotic Lesion Echogenicity and Severity at Standard US with Intraplaque Neovascularization Detected at Contrast-enhanced US
Radiology,
February 1, 2011;
258(2):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Caplice and K. Martin
Contrast-Enhanced Ultrasound and the Enigma of Plaque Neovascularization
J. Am. Coll. Cardiol. Img.,
December 1, 2010;
3(12):
1273 - 1275.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Suarez
Microregulation of Plaque Neovascularization
Arterioscler Thromb Vasc Biol,
August 1, 2010;
30(8):
1500 - 1501.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Massaro, A. Zampolli, E. Scoditti, M. A. Carluccio, C. Storelli, A. Distante, and R. De Caterina
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability
Cardiovasc Res,
May 1, 2010;
86(2):
311 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Nam, C.-W. Ni, A. Rezvan, J. Suo, K. Budzyn, A. Llanos, D. Harrison, D. Giddens, and H. Jo
Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis
Am J Physiol Heart Circ Physiol,
October 1, 2009;
297(4):
H1535 - H1543.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Jaffe, G. Leung, N. R. Munce, A. S. Thind, H. Leong-Poi, K. J.T. Anderson, X. Qi, J. Trogadis, A. Nadler, D. Shiff, et al.
Natural History of Experimental Arterial Chronic Total Occlusions
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1148 - 1158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Magnoni, S. Coli, M. M. Marrocco-Trischitta, G. Melisurgo, D. De Dominicis, D. Cianflone, R. Chiesa, S. B. Feinstein, and A. Maseri
Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries
Eur Heart J Cardiovasc Imaging,
March 1, 2009;
10(2):
260 - 264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Winter, S. D. Caruthers, H. Zhang, T. A. Williams, S. A. Wickline, and G. M. Lanza
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
J. Am. Coll. Cardiol. Img.,
September 1, 2008;
1(5):
624 - 634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Folts
Arterial Blood Pressure Gradient Across Vulnerable Plaque Might Increase Rupture
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2440 - 2440.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Doyle and N. Caplice
Reply
J. Am. Coll. Cardiol.,
December 18, 2007;
50(25):
2440 - 2440.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. L. Ritman and A. Lerman
The dynamic vasa vasorum
Cardiovasc Res,
September 1, 2007;
75(4):
649 - 658.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Herrmann and A. Lerman
Atherosclerosis in the Back Yard
J. Am. Coll. Cardiol.,
May 29, 2007;
49(21):
2102 - 2104.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
